Page last updated: 2024-09-05

azd2563 and opc-67683

azd2563 has been researched along with opc-67683 in 2 studies

Compound Research Comparison

Studies
(azd2563)
Trials
(azd2563)
Recent Studies (post-2010)
(azd2563)
Studies
(opc-67683)
Trials
(opc-67683)
Recent Studies (post-2010) (opc-67683)
290924017225

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baulard, AR; Crauste, C; Déprez, B; Flipo, M; Villemagne, B; Willand, N1
Jeong, BH; Koh, WJ; Kwon, YS1

Reviews

2 review(s) available for azd2563 and opc-67683

ArticleYear
Tuberculosis: the drug development pipeline at a glance.
    European journal of medicinal chemistry, 2012, Volume: 51

    Topics: Animals; Antitubercular Agents; Clinical Trials as Topic; Drug Discovery; Humans; Tuberculosis

2012
Tuberculosis: clinical trials and new drug regimens.
    Current opinion in pulmonary medicine, 2014, Volume: 20, Issue:3

    Topics: Acetamides; Adamantane; Antitubercular Agents; Clinical Trials as Topic; Diarylquinolines; Drug Administration Schedule; Drug Design; Ethylenediamines; Female; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Male; Moxifloxacin; Nitroimidazoles; Oxazoles; Oxazolidinones; Spiro Compounds; Thiazines; Tuberculosis; Tuberculosis, Multidrug-Resistant

2014